Selective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site
Clinical Journal of Gastroenterology · 2026
DOI: 10.1007/s12328-026-02437-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, 2026. Verfasst von Toshihito Ogasawara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hepato-Biliary-Pancreatic Surgery, Department of Gastrointestinal Surgery, Tokai University, Hachioji Hospital, 1838 Ishikawa, Hachioji, Tokyo, 192-0…. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Drainage, Bile Ducts, Intrahepatic, Carcinoma, Papillary. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tokai University, Isehara Campus.
Abstract (Originalsprache)
Background
Intraductal papillary neoplasm of the bile duct (IPNB) often presents with marked ductal dilatation due to excessive mucin secretion, which can make it challenging to distinguish the primary tumor site from secondary dilatation. Case presentation An 83-year-old woman presented with obstructive jaundice and bilateral biliary dilatation. Initial imaging, including CT, MRI, and PET-CT, failed to localize the tumor. While the first peroral cholangioscopy (POCS) was unsuccessful due to viscous bile, a second POCS identified a papillary lesion distal to the confluence of the B2 and B3 bile ducts. To determine the appropriate resection range, an endoscopic nasobiliary drainage (ENBD) tube was selectively placed in the right hepatic duct. The drainage of normal-colored, non-viscous bile and subsequent resolution of jaundice suggested that the right-sided dilatation was caused by mucin reflux from the left liver, rather than direct tumor involvement. The patient successfully underwent a curative left hepatectomy, including caudate lobectomy. Histopathology confirmed type 1 IPNB with high-grade atypia (carcinoma in situ) and negative surgical margins.
Conclusion
POCS combined with selective ENBD may provide a valuable strategy for determining the surgical extent in mucin-producing IPNB when the primary site is difficult to identify using conventional imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepato-Biliary-Pancreatic Surgery, Department of Gastrointestinal Surgery, Tokai University, Hachioji Hospital, 1838 Ishikawa, Hachioji, Tokyo, 192-0032, Japan.
- Hepato-Biliary-Pancreatic Surgery, Department of Gastrointestinal Surgery, Tokai University, Hachioji Hospital, 1838 Ishikawa, Hachioji, Tokyo, 192-0032, Japan. jkaneko01@gmail.com.
- Department of Gastroenterology, Tokai University, Hachioji Hospital, Tokyo, Japan.
- Department of Pathology, Tokai University, Hachioji Hospital, Tokyo, Japan.
Förderung
- Tokai University, Isehara Campus
Zitieren
APA
Ogasawara, T., Kaneko, J., Izumi, H., Tazawa, Y., Nagata, J., Hirose, S., Ito, H., Sugiyama, T., Tajiri, T., & Suzuki, T. (2026). Selective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02437-7
Vancouver
Ogasawara T, Kaneko J, Izumi H, Tazawa Y, Nagata J, Hirose S, et al. Selective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site. Clinical Journal of Gastroenterology. 2026. doi:10.1007/s12328-026-02437-7
BibTeX
@article{Ogasawara2026,
author = {Ogasawara, Toshihito and Kaneko, Junichi and Izumi, Hideki and Tazawa, Yosuke and Nagata, Junko and Hirose, Shunji and Ito, Hiroyuki and Sugiyama, Tomoko and Tajiri, Takuma and Suzuki, Takayoshi},
title = {Selective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site},
journal = {Clinical Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s12328-026-02437-7}
}
EUVIMED